Chronix Biomedical completes Series E financing

[News]

Chronix Biomedical today announced that it has completed a Series E financing that raised $1.8 million from existing and new investors. Chronix is developing disease-specific biomarkers based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells. Chronix's serum DNA biomarkers are applicable to a wide range of cancers and other chronic diseases.

More... (http://www.news-medical.net/news/20100920/Chronix-Biomedical-completes-Series-E-financing.aspx)